News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Afamelanotide in fair-skinned Parkinson’s patients

2024 Announcements . Clinical . News

18.06.2024

News Kommuniqué III

Corporate . News . Newsletter

11.06.2024

News Communiqué III

2024 Announcements . Corporate . News

11.06.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

05.06.2024

CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria

2024 Announcements . Clinical . News

03.06.2024

Notice of ceasing to be a substantial holder

2024 Announcements . Corporate . News

24.05.2024

CLINUVEL and Valentech enter SCENESSE® LATAM partnership

2024 Announcements . Financial . News . Regulatory

23.05.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

14.05.2024

Notice of initial substantial holder

2024 Announcements . Corporate . News

14.05.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

10.05.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

06.05.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

03.05.2024

Sydney Capital Markets Briefing

2024 Announcements . Corporate . News

01.05.2024

.

Go To Top